Active, Not Recruiting
A Comparative Study of the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus Involving Multiple Units, Based on Previous Data.
NCT07053137
- Conditions
- Autoimmune Diseases, Belimumab, Connective Tissue Diseases, +6 more
- Locations
-
- Qianfoshan Hospital Jinan, Shandong, China